Drug Pricing—The Next Compliance Waterloo

My latest article co-authored with Nicodemo Fiorentino and Jennifer O’Leary is available as a free download from the Mitchell Hamline Law Review.     The current drug pricing war pits the pharmaceutical companies against doctors, hospitals, insurers, regulators, and consumers. The pharmaceutical industry has been fighting this war for more than two decades and is now engaged in a rearguard action. Their actions may delay the tidal wave of regulatory…

Whitelaw Compliance Group to Attend West Chester University & Grow PA Discussion about Ethical Decision Making

On Thursday, September 27, 2018,  Whitelaw Compliance Group will be attending the open discussion hosted by West Chester University and Grow PA.  The discussion will focus on how to provide students with ethical tools to meet future employer needs.  It takes place at West Chester University.  For more information click the link.

Have Your Cake & Write a Script Too

Stepping out of her car, Sally Pharmrep glanced again at her watch.  If she was late, it would not be well received.  Reaching into the back seat of her white, four-door Camry, she pulled out the large sheet cake and, of course, the balloons.  After all, it was Dr. ThoughtLeader’s birthday and he loved balloons. . . This is neither a law school case study nor a piece of ancient compliance history. …

MISSING THE MARKET: GOVERNMENT STANDARDS ARE UNDERMINING COMPLIANCE EFFORTS IN SMALLER LIFE SCIENCE COMPANIES

First introduced into life sciences more than two decades ago as the result of a government settlement, compliance officers and compliance departments are now considered essential for pharmaceutical and medical device companies. Without them, life science companies stand little chance of successfully navigating and managing the legal and compliance risks inherent in this highly regulated industry. However, the life sciences industry is no longer dominated by large market cap companies.…